Evercore ISI Group Maintains Outperform on Cardinal Health, Lowers Price Target to $240

Benzinga Newsdesk www.benzinga.com Negative 94.8%

Neg 94.8% Neu 0% Pos 0%

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and lowers the price target from $260 to $240.